Robuta

https://events.diabetes.org/p/s/nanogalaxy-a-novel-hydrophilic-nanoparticle-mrna-based-platform-induces-t-cell-responses-in-nonhuman-primates-and-immune-tolerance-in-a-murine-type-1-diabetes-model-5782 Nanogalaxy, a Novel Hydrophilic Nanoparticle MRNA-Based Platform, Induces T Cell Responses in... Disclosures - J.LU: None. S.WONG: None. C.A.MEDINA: None. K.B.WALSH: Employee; Current; GenEdit, Employee; Ended; Genentech, Inc.. H.ZHANG: None. D.NEWSTROM:...